Separation Systems For Commercial Biotechnology Market To Reach $40.55 Billion By 2030

Separation Systems For Commercial Biotechnology Market Growth & Trends

The global separation system for commercial biotechnology market size is expected to reach USD 40.55 billion by 2030, expanding at a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.

Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for the production of food & cosmetics, agriculture, plastics, and chemicals.

Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand for potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.

Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.

 Request a free sample copy or view report summary: Separation Systems for Commercial Biotechnology Market Report

Separation Systems For Commercial Biotechnology Market Report Highlights

• Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment.

• However, modern methods are anticipated to grow at the fastest pace in the coming years due to the rise in adoption of these technologies.

• Technological advancements in product capabilities are anticipated to boost the separation systems for commercial biotechnology market.

• Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics.

• Rising prevalence of various chronic disorders is indirectly boosting growth.

• North America dominated the market with adequate administrative support, extensive research, and well-established industrial framework.

• Asia Pacific region is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support.

• Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systems.

Separation Systems For Commercial Biotechnology Market Segmentation

Grand View Research has segmented the global separation systems for commercial biotechnology market report based on method, application, and region:

Separation Systems For Commercial Biotechnology Method Outlook (Revenue, USD Million, 2018 - 2030)

• Conventional Methods

  • Chromatography

  • Flow Cytometry

  • Membrane Filtration

  • Electrophoresis

  • Centrifugation

• Modern Methods

  • Microarray

  • Lab-on-a-chip

  • Magnetic Separation

  • Biochip

Separation Systems For Commercial Biotechnology Application Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical

  • Vaccines

  • Proteins

  • Hormones/Insulin

  • Enzymes

  • Human Blood Plasma Fractionation

  • Mammalian Cell Cultures

• Food & Cosmetics

• Agriculture

• Others

Separation Systems For Commercial Biotechnology Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Separation Systems For Commercial Biotechnology Market

• Thermo Fisher Scientific Inc.

• QIAGEN

• Horizon Discovery Ltd.

• OriGene Technologies, Inc.

• Oxford Biomedica PLC

• SignaGen Laboratories

• Flash Therapeutics

• Takara Bio Inc.

• Bio-Rad Laboratories, Inc.

• System Biosciences, LLC.

• Promega Corporation

• F. Hoffmann-La Roche Ltd

• Revvity

• Catalent, Inc